Journal Mobile Options
Table of Contents
Vol. 70, No. 1, 2008
Issue release date: February 2008
ORL 2008;70:6–15
(DOI:10.1159/000111042)

Evidence for a Viral Neuropathy in Recurrent Vertigo

Gacek R.R.
Department of Otolaryngology-Head and Neck Surgery, University of Massachusetts Medical School, Worcester, Mass., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The concept that reactivation of latent neurotropic viruses (i.e. Herpesviridae group) in the vestibular ganglion is responsible for recurrent vestibulopathies is presented. A similar histopathologic degeneration of vestibular ganglion cells in vestibular neuronitis (VN), Ménière’s disease and benign paroxysmal positional vertigo is presented to support this concept. The clinical response (relief of vertigo) to the administration of antiviral medication in these syndromes provides practical evidence of a viral neuropathy in patients with recurrent vertigo. Relief of vertigo after this treatment was 90% in VN, Ménière’s disease and VN. The relief of positional vertigo (benign paroxysmal positional vertigo) was 66%.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Nedzelski J, Barber HO, Mclmogl L: Diagnosis in a dizziness unit. J Otolarngol 1986;15:101–104.
  2. Smith IW, Peutherer JF: The incidence of herpes virus hominis antibody in population. J Hyg (Camb) 1967;65:395–408
  3. Herold RC, Wu Dunn D, Sultys N, Spear PG: Glycoprotein C of herpes simplex virus type I plays a principal role in the absorption of virus to cells and infertility. J Virol 1991;65:1090–1098.
  4. WuDunn D, Spear PG: Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 1989;63:52–58.
  5. Lumio JS, Aho J: Vestibular neuronitis. Ann Otol Rhinol Laryngol 1964;74:264–270.

    External Resources

  6. Ashan G, Stahle J: Vestibular neuritis. J Laryngol Otol 1956;70:497–511.

    External Resources

  7. Merifield DO: Self-limited idiopathic vertigo (epidemic vertigo). Arch Otolaryngol 1965;81:355–358.
  8. Coats A: Vestibular neuronitis. Acta Otolaryngol (Stockh) 1969;251:1–32.
  9. Schimizu T, Sekitani T, Hirata T, Hara H: Serum viral antibody titer in vestibular neuronitis. Acta Otolaryngol Suppl (Stockh) 1993;503:74–78.

    External Resources

  10. Dix MR, Hallpike CS: The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system. Ann Otol Rhinol Laryngol 1952;61:987–1016.
  11. Schuknecht HF, Kitamura K: Vestibular neuritis. Ann Otol Rhinol Laryngol 1981;90(suppl 78):1–19.
  12. Nadol JB: Vestibular neuritis. Otolaryngol Head Neck Surg 1995;112:162–172.
  13. Arbusow V, Schulz P, Strupp M, Dieterich M, et al: Distribution of herpes simplex virus type I in human reticulate and vestibular ganglion: implications for vestibular neuritis. Ann Neurol 1999;46:416–419.
  14. Gacek RR: The pathology of facial and vestibular neuronitis. Am J Otolaryngol 1999;20:202–210.
  15. Baringer JR, Swoveland P: Recovery of herpes simplex virus from human trigeminal ganglions. NEMJ 1973;288:648–650.
  16. Denny-Brown D, Adams RD, Fitzgerald PJ: Pathologic features of herpes zoster. A note on reticulate herpes. Arch Neurol Psychiatry 1949;512:216–231.
  17. Fenton JE, Shirazi A, Turner J, Fagan P: Atypical vestibular neurons: a case report. Otolaryngol Head Neck Surg 1995;112:738–741.
  18. Pitovski DV, Robinson AM, Garcia-lbanez E, et al: Presence of HSV-I gene products characteristic of active infection in the vestibular ganglion of patients diagnosed with acute Ménière’s disease (abstract 457). 22 Annu Midwinter Res Meet Assoc Res Otolaryngol, St. Petersburg, Fla., February 1999.
  19. Tsuji K, Velazques-Vallasenor L, Rauch S, Glynn R, Wall C III, Merchant S: Ménière’s disease: temporal bone studies of the human peripheral vestibular system. Ann Otol Rhinol Laryngol 2000;109(suppl 181):26–31.
  20. Gacek RR, Gacek MR: The three faces of vestibular ganglionitis. Ann Otol Rhinol Laryngol 2002;111:103–114.
  21. Wittmaack K: Die entzündlichen Erkankungsprozesse des Gehörorganes; in Wittmaack K (ed): Handbuch der speziellen Pathologischen Anatomie und Histologie. Berlin, Springer, 1926, pp 102–379.
  22. Davis GL: Cytomegalovirus in the inner ear. Case report and electron microscopic study. Ann Otol Rhinol Laryngol 1969;78:1178–1188.
  23. Schuknecht HF: Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol 1978;87:743–748.
  24. Kuypers HG, Ugolini G: Viruses as transneuronal tracers. Trends Neurosci 1990;13:71–75.
  25. Lavail JH, Topp KS, Giblin PA, et al: Factors that contribute to the transneural spread of herpes simplex virus. J Neurosci Res 1997;49:485–496.
  26. Arbusow V, Strupp M, Wasicky R, Hom AKE, Schulz P, Brandt T: Detection of herpes simplex virus type I in human vestibular nuclei. Neurology 2000;55:880–882.
  27. Bachor E, Wright CG, Karmody CS: The incidence and distribution of cupular deposits in the pediatric vestibular labyrinth. Laryngoscope 2002;112:147–151.
  28. Moriary B, Rutka J, Hawke M: The incidence and distribution of cupular deposits in the labyrinth. Laryngoscope 1992;102:56–59.

    External Resources

  29. Gacek RR: Pathology of benign paroxysmal positional vertigo revisited. Ann Otol Rhinol Laryngol 2003;112:574–582.
  30. Parnes LS: Update on posterior canal occlusion for benign paroxysmal positional vertigo. Otolaryngol Clin North Am 1996;29:333–342.
  31. Fluur E, Mellstrom A: Saccular stimulation and oculi motor reactions. Laryngoscope 1970;80:1713–1721.
  32. Fluur E, Mellstrom A: The otolith organs and the nystagmus problem. Acta Otolaryngol (Stockh) 1973;76:438–442.
  33. Fluur E: Positional and positioning nystagmus as a result of utriculo-cupular integration. Acta Otolaryngol (Stockh) 1974;78:19–27.
  34. Epley JM: The canalith repositioning procedure for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992;107:399–404.
  35. Gacek RR, Schoonmaker JE: Morphologic changes in the vestibular nerves and nuclei after labyrinthectomy in the cat: a case for the neurotropic hypothesis in vestibular compensation. Acta Otolaryngol (Stockh) 1997;117:244–249.
  36. Gacek RR, Gacek MR: Ménière’s disease as a manifestation of vestibular ganglionitis. Ann J Otolaryngol 2001;22:241–250.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50